Swiss pharmaceutical company Roche Holding AG (ROG.VX) Wednesday announced the launch of a clinical laboratory system to increase laboratory testing efficiency and to accommodate molecular diagnostic needs.

MAIN FACTS:

- The cobas 4800 System combines CE-marked in vitro diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae and human papillomavirus testing with fully-automated sample preparation and real-time polymerase chain reaction technology.

Company Web site: http://www.roche.com

(source:reproduced)